News Archive
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body.
At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J. Barth Jr., M.D., and three fellow researchers are making the case for a particular combination of treatments to stop the tumors in their tracks.
A quarter century ago, the Pan American Health Organization (PAHO) and its member countries launched a unique procurement and financing mechanism to buy vaccines, syringes, and "cold chain" equipment – the basic components of their immunization programs.
Gilead Sciences, Inc. today announced the publication of data from DAR-311 (DORADO), a Phase III clinical trial evaluating the company's once-daily oral endothelin receptor antagonist (ERA) darusentan as an add-on treatment for resistant hypertension, defined as the failure to achieve blood pressure goal while adhering to full doses of an appropriate three (or more) drug antihypertensive regimen that includes a diuretic.
› Verified 8 days ago